The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
"Contact to index case" means Human-to-Human transmission. I'm sure you understand camels were not involved when one patient passed to 2 others in a healthcare facility. Whether camels were involved as a first step will pale into insignificance if more human-to-human cases are contact traced.
And no, it is not " reasonable to assume that if there was going to be a wider outbreak it would have happened by now" According to the NIH , the extent of asymptomatic MERS-CoV cases is about 10% from different studies.
Finally in case it slipped your mind, the company we are invested in, Synairgen, have already conducted pre-clinical research of SNG001 showing the inhibition of Middle East Respiratory Syndrome-Coronavirus in cell-based assays.
Https://www.telegraph.co.uk/global-health/science-and-disease/mers-outbreak-saudi-arabia-middle-east-respiratory-syndrome/
“The health analytic firm Airfinty, which monitors disease outbreaks globally, said there was a “high threat” for the city Riyadh.
“Mers-CoV [is] still around and still a threat,” Prof Peter Horby, director of the Pandemic Sciences Institute at the University of Oxford said on X. “[Saudi Arabia] has great experience of detecting and controlling health-care associated MERS transmission – other places are less aware and less prepared. ”
"and more importantly shows incredible data to back up its patient identification techniques".
work for AZ after all. Like Sakura.
I would lower expectations that the company will share commercially sensitive information like this with just anyone. You could work for a competitor after all.
"never materialised". I'd qualify that with a hefty "Yet".
My position has not moved DocDan. One outcome does not limit the other from being possible. I would assume that something is going on. And that they cannot update us yet.
My guess is it's less a case of "Synairgen have essentially decided to shut up shop in terms of any communication at all to shareholders", and more a case of the company being bound by NDA/s. The degree of silence is unprecedented and the hiring in November was silent, and coordinated. For good reason I hope.
Small observation but think you'll find the majority are actually trolls pretending to be "individuals expressing concern are frustrated investors caught up in the unfortunate Sprinter outcome". Not really the same thing.
Not sure if the article is visible to all (?) but the summary at end states that "“We’re not going to be ready,” Katrine Wallace, epidemiologist at the University of Illinois, said. “We’re not even dealing with what’s right in front of us.”
Posting IN THE CONTEXT of current H5N1 threat in the US. We know that "Pre-clinical research conducted by Synairgen of IFN-β (at concentrations readily achievable following inhaled delivery of SNG001) shows the inhibition of a broad range of viruses in cell-based assays including: viruses which cause seasonal cold (e.g., RSV, Rhinovirus) and flu infections highly pathogenic viruses such as H5N1 ‘bird flu’ and Middle East Respiratory Syndrome-Coronavirus (MERS-CoV)".
MrCosts2much.
Then again, he may be travelling in from his trading desk at Citadel, 120 London Wall London. ..
Fantasy Heights, 1 Joke Street, Liarsville H0H0 XXX.
Did I miss anything?
You're the joke.
The last Paul Cuddon Broker Note information I have is dd 17 March 2022 and it was on the Activ-2 update but prior Sprinter results:
"Current share price: 26p
Target price: 220p"
NUMIS / Paul Cuddon – 17 March 2022
Was there a later report published after Sprinter?
DB will not have published a forecast this isn't current. Any previous forecast and rating will have been checked for accuracy against all current available information (peer,market sector - etc) before being published. I don't believe there is any previous note published by Paul Cuddon that pegged a forecast of 8p, unless I missed it? So I think this has to be new, and based on current info.
I don’t think I’ve ever come across an investor who is equally dismayed by the thought of an update or a positive broker rating. You seem happiest at the thought of the company failing. Such a strange behaviour.
DocDan, the “number” is not an arbitrary one. It is based on is level of analysis of information currently available to the the Analyst.
DB
Cheer up Costas. It could have been 3p. Or 2p. Or 1p.
It shows DN analyst believes it's worth more than you do. Which is odd, seeing as you are in investor?
Thanks Doc83. It could be that it was suspended for that time after Numis acquisition and now it's been rubber stamped as active by DB. Would be good to see if you get a response. 8p forecast, 2p higher than SP, signals some belief that they don't see the company running out of money suddenly or hitting a wall?
Doc83, Deutsch Bank bank concluded Numis takeover 7 months ago. This coverage is new, so I’d assume DB initiated.